Generation Bio Co.

NASDAQ: GBIO · Real-Time Price · USD
0.37
0.00 (1.20%)
At close: Jun 06, 2025, 9:52 AM

Generation Bio Statistics

Share Statistics

Generation Bio has 67.04M shares outstanding. The number of shares has increased by 0.72% in one year.

67.04M
0.72%
0.32%
80.69%
n/a
4,477
0.9%

Short Selling Information

The latest short interest is 1.89M, so 2.82% of the outstanding shares have been sold short.

1.89M
2.82%
4.11%
3.21

Valuation Ratios

The PE ratio is -0.54 and the forward PE ratio is -0.36. Generation Bio's PEG ratio is -0.53.

-0.54
-0.36
3.55
0.5
0.82
-0.78
-0.53
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Generation Bio.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.5, with a Debt / Equity ratio of 1.09.

5.5
5.5
1.09
-1.26
-1.03
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$172,973.91
$-1,144,939.13
115
0.09
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -88.86% in the last 52 weeks. The beta is 2.66, so Generation Bio's price volatility has been higher than the market average.

2.66
-88.86%
0.39
1.25
42.69
497,647

Income Statement

In the last 12 months, Generation Bio had revenue of 19.89M and earned -131.67M in profits. Earnings per share was -1.98.

19.89M
19.89M
-142.39M
-131.67M
-74.26M
-79.19M
-1.98
Full Income Statement

Balance Sheet

The company has 76.3M in cash and 93.56M in debt, giving a net cash position of -17.26M.

76.3M
93.56M
-17.26M
-703.04M
201.35M
145.52M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -88.56M and capital expenditures -2.4M, giving a free cash flow of -90.96M.

-88.56M
-2.4M
-90.96M
-1.37
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -715.82% and -661.91%.

100%
-715.82%
-661.91%
-661.91%
-373.33%
-715.82%
-457.29%

Dividends & Yields

GBIO does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for GBIO is $8, which is 2062.2% higher than the current price. The consensus rating is "Buy".

$8
2062.2%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-5.1
2